Suneel Gupta serves as Executive at Protagonist Therapeutics, Inc, where they oversee executive responsibilities. Since joining the company, Suneel Gupta has executed 14 insider transactions totaling $278.9K, demonstrating a bullish approach to their equity position. Their most recent transaction on Feb 26, 2024 involved selling 4,282 shares valued at $126.4K.
Suneel Gupta currently holds 183,285 shares of Protagonist Therapeutics, Inc (PTGX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Suneel Gupta has been a net buyer of PTGX stock. They have purchased $153.9K and sold $125.0K worth of shares.
Suneel Gupta's most recent insider trade was on Feb 26, 2024, when they sold 4,282 shares at $29.53 per share.
Get notified when new Form 4 filings are submitted
| $25.00 |
| Planned |
| Jan 9, 2024 | PTGX | $36.9K | Option Exercise | 5,000 | $7.38 | Planned |
| Jan 2, 2024 | PTGX | $0 | Award | 19,250 | $N/A | Discretionary |
| Oct 19, 2023 | PTGX | $147.6K | Option Exercise | 20,000 | $7.38 | Discretionary |
| May 31, 2023 | PTGX | $0 | Award | 12,000 | $N/A | Discretionary |
| May 31, 2023 | PTGX | $108.2K | Payment | 4,150 | $26.07 | Discretionary |
| Jan 16, 2023 | PTGX | $0 | Award | 20,625 | $N/A | Discretionary |
| Apr 26, 2022 | PTGX | $295.2K | Option Exercise | 40,000 | $7.38 | Discretionary |
| Feb 28, 2022 | PTGX | $15.8K | Payment | 649 | $24.28 | Discretionary |
| Feb 15, 2022 | PTGX | $0 | Award | 12,500 | $N/A | Discretionary |
| Feb 26, 2021 | PTGX | $0 | Award | 12,000 | $N/A | Discretionary |
| Dec 3, 2019 | PTGX | $153.9K | Purchase | 30,000 | $5.13 | Discretionary |
| Feb 28, 2019 | PTGX | $0 | Award | 7,500 | $N/A | Discretionary |